Management of precancerous anal intraepithelial lesions in human immunodeficiency virus-positive men who have sex with men: Clinical effectiveness and cost-effectiveness.
Ashish A DeshmukhElizabeth Y ChiaoScott B CantorElizabeth A StierStephen E GoldstoneAlan G NyitrayTimothy WilkinXiaojie WangJagpreet ChhatwalPublished in: Cancer (2017)
The management of HSIL in HIV-positive MSM who are 38 years old or older with treatment plus adjuvant qHPV vaccination is likely to be cost-effective. The conservative approach of no treatment is likely to be cost-effective in younger patients. Cancer 2017;123:4709-4719. © 2017 American Cancer Society.
Keyphrases
- men who have sex with men
- hiv positive
- human immunodeficiency virus
- hiv testing
- antiretroviral therapy
- south africa
- papillary thyroid
- hepatitis c virus
- end stage renal disease
- squamous cell
- high grade
- early stage
- hiv infected
- ejection fraction
- systematic review
- physical activity
- chronic kidney disease
- squamous cell carcinoma
- hiv aids
- lymph node metastasis
- young adults
- peritoneal dialysis
- prognostic factors
- community dwelling